Status | Study |
RECRUITING |
Study Name: A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria Condition: Hyperoxaluria Date: 2023-10-18 Interventions: Oral Capsule |
Not yet recruiting |
Study Name: A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria Condition: Primary Hyperoxaluria Date: 2017-04-07 Interventions: Biological: Oxabact OC5 - Oxalobacter formigenes HC-1 |
Completed |
Study Name: A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria Condition: Secondary Hyperoxaluria Nephrolithiasis Date: 2017-03-20 Interventions: Other: Oxalate-rich Test Meal |
Active, not recruiting |
Study Name: Proteomics of Primary Hyperoxaluria Type 1 Condition: Primary Hyperoxaluria Type 1 Date: 2017-02-09 Interventions: Other: Observational Not an interventional study. Analyses of previously collected urine specimens and d |
Completed |
Study Name: IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND IDIOPATHIC HYPERCALCIURIA Condition: Primary Hyperoxaluria Type 1 Idiopathic Hypercalciuria Date: 2016-07-08 Interventions: Other: Urines samples 24-hour |
Not yet recruiting |
Study Name: Descriptive Analysis of Gut Microbiome Alterations in Hyperoxaluric Patients Condition: Oxalate, Primary Hyperoxaluria, Microbiome Date: 2016-05-25 |
Active, not recruiting |
Study Name: A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1) Condition: Primary Hyperoxaluria Type 1 Date: 2016-05-18 Interventions: Drug: DCR-PH1 IV infusion of DCR-PH1 |
Recruiting |
Study Name: Study of ALN-GO1 in Healthy Adult Subjects and Patients With Primary Hyperoxaluria Type 1 Condition: Primary Hyperoxaluria Type 1 (PH1) Date: 2016-03-03 Interventions: Drug: ALN-GO1 Single or multip |
Completed |
Study Name: Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days Condition: Secondary Hyperoxaluria Nephrolithiasis Date: 2015-09-10 Interventions: Drug: ALLN-177 ALLN-177 7,500 |
Completed |
Study Name: Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones Condition: Secondary Hyperoxaluria Nephrolithiasis Date: 2015-07-17 Interventions: Drug: ALLN-177 low dose ALLN-1 |